Mesoblast (MESO) Asset Utilization Ratio (2017 - 2023)
Mesoblast (MESO) posted quarterly Asset Utilization Ratio of 0.01 for Q2 2023, down 18.62% year-on-year from 0.02 in Q2 2022, and down 4.43% on a QoQ basis from 0.01 in Q1 2023.
Mesoblast (MESO) Asset Utilization Ratio (2017 - 2023) Analysis & Trends
Mesoblast (MESO) has reported Asset Utilization Ratio for 7 consecutive years, with 0.01 the latest figure, recorded in Q2 2023.
- Quarterly Asset Utilization Ratio fell 18.62% year-over-year to 0.01 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was 0.01 (down 18.62% YoY) and the FY2025 annual result came in at 0.02, up 168.29% from the prior year.
- Asset Utilization Ratio eased to 0.01 in Q2 2023 per MESO's latest filing, from 0.01 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for MESO reached as high as 0.05 in Q2 2020 and fell as low as 0.01 in Q1 2019.
- A 5-year average of 0.02 and a median of 0.01 in 2021 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2020 — Asset Utilization Ratio jumped 479.53% — and 2021, when it slumped 74.99%.
- Year by year, Asset Utilization Ratio stood at 0.01 in 2019, then jumped by 351.37% to 0.05 in 2020, then sank by 65.9% to 0.02 in 2021, then retreated by 19.06% to 0.01 in 2022, then dropped by 2.78% to 0.01 in 2023.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.01, 0.01, and 0.01 for Q2 2023, Q1 2023, and Q4 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.02 |
| Mar 31, 2022 | 0.02 |
| Dec 31, 2021 | 0.02 |
| Sep 30, 2021 | 0.01 |
| Jun 30, 2021 | 0.01 |
| Mar 31, 2021 | 0.04 |
| Dec 31, 2020 | 0.05 |
| Sep 30, 2020 | 0.04 |
| Jun 30, 2020 | 0.05 |
| Mar 31, 2020 | 0.01 |
| Dec 31, 2019 | 0.01 |
| Sep 30, 2019 | 0.01 |
| Jun 30, 2019 | 0.01 |
| Mar 31, 2019 | 0.01 |
| Dec 31, 2018 | 0.01 |
| Sep 30, 2018 | 0.01 |